Overall Score

Revenue Model

Primarily generates revenue from home health, hospice, and personal care services, creating a recurring care-delivery model.

Revenue per share is 11.95 and price-to-sales is 0.90, indicating a relatively low sales multiple for the current scale.

Gross margin remains solid at 32.0%, supporting a service-based model with meaningful pricing and mix leverage.

Profitability

EBIT margin is 10.7% and EBITDA margin is 11.5%, showing the business is operating profitably.

Net margin is 10.6% and return on assets is 13.0%, indicating decent earnings conversion from the asset base.

Return on invested capital is 16.8%, suggesting the core business is generating acceptable returns despite leverage.

Cash Generation

Operating cash flow ratio is 0.34 and free cash flow to operating cash flow is 98.4%, indicating strong conversion of operating cash into free cash flow.

Free cash flow yield is 5.9% and price-to-free-cash-flow is 17.1x, implying cash generation is positive but not especially cheap.

Working capital is positive at 66.8M, supporting near-term liquidity needs.

Balance Sheet

Current ratio is 1.16, so short-term liquidity is adequate but not abundant.

Net debt to EBITDA is 4.16x and debt to equity is 4.67x, reflecting a leveraged capital structure.

Interest coverage is 2.32x, which leaves limited cushion if operating performance weakens.

Competitive Position

Fixed asset turnover is 45.8x and asset turnover is 1.24x, indicating efficient use of the asset base.

Receivables turnover of 7.7x and a 47.3-day operating cycle suggest manageable working-capital efficiency.

The business appears operationally efficient, but leverage and modest liquidity temper the overall moat assessment.